Researchers are excited about this new drug, a novel dual agonist showing promising results in initial trials for weight loss . It acts by targeting two pathways : GLP-1 and GIP, these, when engaged , https://ambernlfo730769.thenerdsblog.com/46861367/this-new-possibility-for-weight-management